CollPlant Biotechnologies Statistics

Total Valuation

CLGN has a market cap or net worth of $43.41 million. The enterprise value is $29.71 million.

Market Cap	43.41M
Enterprise Value	29.71M

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024, before market open.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

CLGN has 11.45 million shares outstanding. The number of shares has increased by 1.97% in one year.

Current Share Class	11.45M
Shares Outstanding	11.45M
Shares Change (YoY)	+1.97%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	30.97%
Owned by Institutions (%)	17.37%
Float	7.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	65.65
Forward PS	34.72
PB Ratio	2.18
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	43.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.27, with a Debt / Equity ratio of 0.16.

Current Ratio	6.27
Quick Ratio	6.07
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.55% and return on invested capital (ROIC) is -36.23%.

Return on Equity (ROE)	-61.55%
Return on Assets (ROA)	-33.77%
Return on Capital (ROIC)	-36.23%
Revenue Per Employee	$9,187
Profits Per Employee	-$232,947
Employee Count	75
Asset Turnover	0.02
Inventory Turnover	2.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.04% in the last 52 weeks. The beta is 0.48, so CLGN's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-32.04%
50-Day Moving Average	4.57
200-Day Moving Average	5.10
Relative Strength Index (RSI)	38.74
Average Volume (20 Days)	16,247

Short Selling Information

Short Interest	14,451
Short Previous Month	8,123
Short % of Shares Out	0.18%
Short % of Float	n/a
Short Ratio (days to cover)	2.00

Income Statement

In the last 12 months, CLGN had revenue of $689,000 and -$17.47 million in losses. Loss per share was -$1.53.

Revenue	689,000
Gross Profit	-1.44M
Operating Income	-18.41M
Pretax Income	-7.50M
Net Income	-17.47M
EBITDA	-17.31M
EBIT	-18.41M
Loss Per Share	-$1.53

Full Income Statement

Balance Sheet

The company has $18.92 million in cash and $3.39 million in debt, giving a net cash position of $15.54 million or $1.36 per share.

Cash & Cash Equivalents	18.92M
Total Debt	3.39M
Net Cash	15.54M
Net Cash Per Share	$1.36
Equity (Book Value)	20.73M
Book Value Per Share	1.81
Working Capital	17.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.75 million and capital expenditures -$756,000, giving a free cash flow of -$3.51 million.

Operating Cash Flow	-2.75M
Capital Expenditures	-756,000
Free Cash Flow	-3.51M
FCF Per Share	-$0.31

Full Cash Flow Statement

Margins

Gross Margin	-209.43%
Operating Margin	-2,671.26%
Pretax Margin	-2,535.70%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-31.90%

Dividends & Yields

CLGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.97%
Shareholder Yield	-1.97%
Earnings Yield	-40.57%
FCF Yield	-8.14%

Analyst Forecast

The average price target for CLGN is $12.50, which is 229.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.50
Price Target Difference	229.82%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.6666666:1.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.6666666:1

Scores

CLGN has an Altman Z-Score of -0.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.25
Piotroski F-Score	1